Centre de recherche en Myologie

Type: Research unit evaluation report

Evaluation campaign: 2017-2018 (group D) - Published on: 07/06/2018

Institution(s) concerned: Université Pierre et Marie Curie - UPMC , Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology ; SVE6 Public Health, Epidemiology, Clinical Research

Scientific field(s): 5 - Biologie, medecine et santé

ERC panel(s): LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS5 Neurosciences and neural disorders: neurobiology, neuroanatomy, neurophysiology, neurochemistry, neuropharmacology, neuroimaging, systems neuroscience, neurological disorders, psychiatry ; LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics

Name of unit teams: Myomatrix & Myonucleus related diseases: Genetics & Pathophysiology ; Pathophysiology and therapy of the autosomal dominant centronuclear myopathy ; Cell and molecular orchestration in muscle regeneration, ageing and diseases ; Repeat Expansion & Myotonic Dystrophy ; Biotherapies and pathophysiology of neuromuscular disorders (Duchenne Muscular Dystrophy, Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy) ; Myasthenia Gravis: etiology, physiopathology and therapeutic approaches ; Inflammatory Muscle and Innovative Therapies ; Signaling Pathways and Striated Muscles ; Neuromuscular connectivity in health and diseases (Channelopathies, Congenital Myasthenic Syndromes and Amyotrophic lateral sclerosis)

Keywords: myologie ; maladies neuromusculaires ; cellules souches ; thérapies géniques et cellulaires ; maladies auto-immunes ; inflammation ; vieillissement ; SVE5